CML
Conference Coverage
Momelotinib hits the mark for deadly bone marrow cancer
Phase-3 study shows superiority to danazol and highlights potential for improving outcomes in anemic myelofibrosis.
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
From the Journals
9/11 first responders show mutations linked to blood cancers
Blood samples from firefighters and emergency workers at Ground Zero show higher burden of clonal hematopoiesis, suggesting need for mutational...
From the Journals
U.S. cancer deaths continue to fall, especially lung cancer
There has been an overall decline of 32% in cancer deaths as of 2019.